Publications by authors named "Gerd Reifschneider"
Article Synopsis
- Cladribine tablets are used to treat relapsing multiple sclerosis (RMS) with a treatment regimen of two annual courses, totaling 20 days, and the study focuses on patient experiences right after its launch.
- A multicenter study in Germany evaluated the effectiveness, tolerability, and patient satisfaction over a 24-week period, involving 491 RMS patients with an average satisfaction score of 75.6 at week 24.
- Most patients reported high treatment satisfaction and an increase in overall satisfaction after switching from other medications, with a majority remaining relapse-free and only a small percentage experiencing adverse events.
Courses of Parkinson's disease (PD) that are complicated by weight loss result in poorer overall treatment outcome and lower quality of life. To determine the contribution of depression, which has not yet been specified in the etiology of weight loss in PD, symptomatology and anamnesis from 215 outpatients diagnosed with PD were assessed using a comprehensive battery of neuropsychiatric scales. A percentage of 31 comorbid depressed patients and a comparison with a control population allowed an accurate characterization of effect sizes, sex differences, and patterns of the contribution of comorbid depression to weight loss.
View Article and Find Full Text PDFBeck depression inventory (BDI-1A) is the gold standard screening tool for Parkinson's disease (PD) depression, but as a result of its complexity, it is of limited suitability as a quick and easy screening device. We, therefore, validate the 5-item WHO-Five Well-being Index (WHO-5) as a screening tool for PD depression. Two hundred thirteen of 215 recruited PD patients (99.
View Article and Find Full Text PDF